BBVA USA Bancshares’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$502K Sell
1,398
-363
-21% -$117K 0.02% 400
2020
Q4
$566K Sell
1,761
-103
-6% -$31.6K 0.03% 372
2020
Q3
$491K Sell
1,864
-7
-0.4% -$1.88K 0.03% 360
2020
Q2
$492K Buy
1,871
+10
+0.5% +$2.67K 0.03% 364
2020
Q1
$422K Buy
1,861
+569
+44% +$155K 0.03% 353
2019
Q4
$390K Buy
+1,292
New +$356K 0.02% 405
2015
Q3
Sell
-3,299
Closed -$541K 474
2015
Q2
$541K Buy
3,299
+99
+3% +$15.8K 0.03% 332
2015
Q1
$494K Sell
3,200
-22
-0.7% -$3.13K 0.02% 392
2014
Q4
$405K Sell
3,222
-4,000
-55% -$494K 0.02% 432
2014
Q3
$864K Buy
7,222
+22
+0.3% +$2.52K 0.04% 299
2014
Q2
$775K Buy
7,200
+150
+2% +$15.5K 0.03% 310
2014
Q1
$702K Hold
7,050
0.03% 316
2013
Q4
$651K Buy
7,050
+3,050
+76% +$271K 0.03% 320
2013
Q3
$334K Hold
4,000
0.02% 410
2013
Q2
$327K Buy
+4,000
New +$299K 0.02% 376

Other funds holding ELV

BBVA USA Bancshares's ELV Position: Q1 2021 in Review

BBVA USA Bancshares reduced its Elevance Health (ELV) stake by 21% in Q1 2021, selling an estimated $117K and leaving 1,398 shares worth $502K. The position accounts for 0.02% of the portfolio, ranked #400.

BBVA USA Bancshares first reported a position in ELV in Q2 2013 and has held it in 15 quarters since. The position peaked at $864K in Q3 2014. 1,212 funds tracked by Wall St. Rank hold ELV as of Q1 2021.

  • BBVA USA Bancshares held 1,398 shares of Elevance Health worth $502K as of Q1 2021.
  • BBVA USA Bancshares sold 363 Elevance Health shares in Q1 2021, an estimated $117K.
  • Elevance Health made up 0.02% of BBVA USA Bancshares's portfolio in Q1 2021, its #400 holding.
  • BBVA USA Bancshares first reported a position in Elevance Health in Q2 2013 and has held it in 15 quarters since.
  • BBVA USA Bancshares's Elevance Health position peaked at $864K in Q3 2014.
  • 1,212 funds tracked by Wall St. Rank held Elevance Health as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.